Make your money go further for just 25p per day

PREMIUM
AIM IHT

Bonkers Bargain: results reflect contract delays

AI imagery

This small medical imaging advanced analytics company delivering insights in neuroscience, had been growing fast over recent years and, following recent share price falls, looks cracking value. Our in-depth commentary here highlights its appeal in a sector which is predicted to grow significantly over the coming years. The order book offers plenty of visibility and this fascinating business is certainly worth a close look. Encouraging results from a drug being developed for Alzheimers disease is positive, although news of contract delays has pushed the shares lower.


IXICO (LON:IXI) is an Artificial Intelligence (‘AI’) data analytics company delivering intelligent insights in neuroscience. Its purpose is to advance medicine and human health in neuroscience by converting raw clinical trial data into clinically meaningful information.


Through the deployment of novel Artificial Intelligence (‘AI’) algorithms, IXICO analyses and interprets brain scans and wearable biosensor data to enable better trial design, patient selection and ultimately better clinical outcomes across all phases of clinical evaluation.

The Group is a…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on IXICO PLC

Episode 19 of the Investor’s Champion Podcast

26/05/2024 · Podcasts

In this episode of the Investors Champion Podcast, hosts Lee and Chris discuss the latest stock…


Bonkers Bargain: results reflect contract delays

21/05/2024 · Company Insights

This small medical imaging advanced analytics company delivering insights in neuroscience, had been growing fast over…


More Company Insights

This Bonkers Bargain is a little gem

19/06/2024

Exciting new AIM arrival but more departures in May

Sign-up to our free email updates

SIGN UP